ArticleCancer medicine2020

RAS and TP53 can predict survival in adults with T-cell lymphoblastic leukemia treated with hyper-CVAD.

Ali Sakhdari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.